Looking to Build Assay Menu, NanoInk to Debut Angiogenesis, Alzheimer's, and Rodent Tox Kits

The new products follow the February launch of a human inflammation cytokine profiling assay, and are part of NanoInk's effort to broaden its business beyond selling instruments and contract research services.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.